Drawing for ENESI

USPTO serial 79296907

ENESI

Reviewed by CopyMark Law Group

Reg. 6532792Status 700Renewal
Filing date
Status date
Registration date
Oct 26, 2021
Examiner
PARK, JENNY K
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENESI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious diseases; pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune disease; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substance for the treatment of infectious and autoimmune diseases; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substancesACTIVE
010Surgical, medical, dental and veterinary apparatus and instruments, namely, needle-free drug administration devices sold empty; drug delivery devices for delivery of drugs; drug delivery apparatus for medical use, delivered through pressure; needle-free drug delivery systems sold empty; actuator devices drug delivery systems, namely, medical solid dose injector sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical injectors, needle-free injectors sold empty; drug delivery devices, namely, medical injectors, needle-free injectors and parts and fittings therefore sold empty; actuator devices for use in drug delivery devices for use, namely, handheld spring-powered devices and handheld gas-powered devices, all in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; parts and fittings for all the aforesaid goodsACTIVE
042Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technology; consultancy in relation to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2022FIMPFINAL DISPOSITION PROCESSED
Jan 26, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 10, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 10, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 8, 2021GPNXNOTIFICATION PROCESSED BY IB
Jul 21, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 21, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 21, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2020RFNTREFUSAL PROCESSED BY IB
Nov 29, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2020RFRRREFUSAL PROCESSED BY MPU
Nov 10, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Nov 2, 2020DOCKASSIGNED TO EXAMINER
Nov 2, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance